Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) shares dropped 3.1% on Monday . The company traded as low as $14.32 and last traded at $14.32. Approximately 221,863 shares traded hands during mid-day trading, a decline of 71% from the average daily volume of 764,351 shares. The stock had previously closed at $14.78. Analysts Set New […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) rose 7.8% during mid-day trading on Monday following insider buying activity. The stock traded as high as $14.85 and last traded at $14.84. Approximately 51,290 shares traded hands during mid-day trading, a decline of 93% from the average daily volume of 770,578 shares. The stock had previously closed […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) Director Dennis Leo Walsh purchased 11,000 shares of Deciphera Pharmaceuticals stock in a transaction that occurred on Wednesday, May 10th. The stock was bought at an average cost of $13.86 per share, with a total value of $152,460.00. Following the completion of the transaction, the director now owns […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Equities research analysts at SVB Leerink cut their Q2 2023 EPS estimates for shares of Deciphera Pharmaceuticals in a research note issued to investors on Wednesday, May 3rd. SVB Leerink analyst A. Berens now forecasts that the company will earn ($0.65) per share for the quarter, down […]
Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Rating) had its price objective decreased by Stifel Nicolaus from $17.00 to $14.00 in a research note issued to investors on Thursday, The Fly reports. Several other analysts have also issued reports on DCPH. HC Wainwright restated a buy rating and issued a $25.00 price target on shares of Deciphera […]